The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Mark H. Pollack

Center for Anxiety and Traumatic Stress Disorders

Massachusetts General Hospital

One Bowdoin Square

Sixth Floor

USA

[email]@partners.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Square, Sixth Floor, USA. 2005 - 2011
  • Psychiatry Department, Massachusetts General Hospital, Boston, MA 02114, United States. 1998 - 2008
  • Massachusetts General Hospital, Simches Research Bldg, 185 Cambridge St, Ste 2200, USA. 2007 - 2008
  • Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden. 2003

References

  1. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. Pollack, M.H., Hoge, E.A., Worthington, J.J., Moshier, S.J., Wechsler, R.S., Brandes, M., Simon, N.M. J. Clin. Psychiatry (2011) [Pubmed]
  2. Refractory generalized anxiety disorder. Pollack, M.H. J. Clin. Psychiatry (2009) [Pubmed]
  3. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. Pollack, M.H., Tiller, J., Xie, F., Trivedi, M.H. J. Clin. Psychopharmacol (2008) [Pubmed]
  4. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. Pollack, M.H., Endicott, J., Liebowitz, M., Russell, J., Detke, M., Spann, M., Ball, S., Swindle, R. J. Psychiatr. Res (2008) [Pubmed]
  5. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Pollack, M.H., Jensen, J.E., Simon, N.M., Kaufman, R.E., Renshaw, P.F. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008) [Pubmed]
  6. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Pollack, M., Kinrys, G., Krystal, A., McCall, W.V., Roth, T., Schaefer, K., Rubens, R., Roach, J., Huang, H., Krishnan, R. Arch. Gen. Psychiatry (2008) [Pubmed]
  7. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. Pollack, M.H., Kornstein, S.G., Spann, M.E., Crits-Christoph, P., Raskin, J., Russell, J.M. J. Psychiatr. Res (2008) [Pubmed]
  8. Novel treatment approaches for refractory anxiety disorders. Pollack, M.H., Otto, M.W., Roy-Byrne, P.P., Coplan, J.D., Rothbaum, B.O., Simon, N.M., Gorman, J.M. Depress. Anxiety (2008) [Pubmed]
  9. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Pollack, M., Mangano, R., Entsuah, R., Tzanis, E., Simon, N.M., Zhang, Y. Psychopharmacology (Berl.) (2007) [Pubmed]
  10. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack, M.H., Lepola, U., Koponen, H., Simon, N.M., Worthington, J.J., Emilien, G., Tzanis, E., Salinas, E., Whitaker, T., Gao, B. Depress. Anxiety (2007) [Pubmed]
  11. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. Pollack, M.H., Simon, N.M., Fagiolini, A., Pitman, R., McNally, R.J., Nierenberg, A.A., Miyahara, S., Sachs, G.S., Perlman, C., Ghaemi, S.N., Thase, M.E., Otto, M.W. J. Clin. Psychiatry (2006) [Pubmed]
  12. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Pollack, M.H., Simon, N.M., Zalta, A.K., Worthington, J.J., Hoge, E.A., Mick, E., Kinrys, G., Oppenheimer, J. Biol. Psychiatry (2006) [Pubmed]
  13. The pharmacotherapy of panic disorder. Pollack, M.H. J. Clin. Psychiatry (2005) [Pubmed]
  14. Comorbid anxiety and depression. Pollack, M.H. J. Clin. Psychiatry (2005) [Pubmed]
  15. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. Pollack, M.H., Roy-Byrne, P.P., Van Ameringen, M., Snyder, H., Brown, C., Ondrasik, J., Rickels, K. J. Clin. Psychiatry (2005) [Pubmed]
  16. Unmet needs in the treatment of anxiety disorders. Pollack, M.H. Psychopharmacol. Bull (2004) [Pubmed]
  17. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. Pollack, M.H., Meoni, P., Otto, M.W., Simon, N., Hackett, D. J. Clin. Psychopharmacol (2003) [Pubmed]
  18. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. Pollack, M.H., Simon, N.M., Worthington, J.J., Doyle, A.L., Peters, P., Toshkov, F., Otto, M.W. J. Psychopharmacol. (Oxford) (2003) [Pubmed]
  19. Treatment of panic disorder: focus on paroxetine. Pollack, M.H., Doyle, A.C. Psychopharmacol. Bull (2003) [Pubmed]
  20. WCA recommendations for the long-term treatment of panic disorder. Pollack, M.H., Allgulander, C., Bandelow, B., Cassano, G.B., Greist, J.H., Hollander, E., Nutt, D.J., Okasha, A., Swinson, R.P. CNS. Spectr (2003) [Pubmed]
  21. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. Pollack, M.H., Rapaport, M.H., Fayyad, R., Otto, M.W., Nierenberg, A.A., Clary, C.M. J. Psychiatr. Res (2002) [Pubmed]
  22. A novel cognitive-behavioral approach for treatment-resistant drug dependence. Pollack, M.H., Penava, S.A., Bolton, E., Worthington, J.J., Allen, G.L., Farach, F.J., Otto, M.W. J. Subst. Abuse. Treat (2002) [Pubmed]
  23. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. Pollack, M.H., Zaninelli, R., Goddard, A., McCafferty, J.P., Bellew, K.M., Burnham, D.B., Iyengar, M.K. J. Clin. Psychiatry (2001) [Pubmed]
  24. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. Pollack, M.H. J. Clin. Psychiatry (2001) [Pubmed]
  25. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. Pollack, M.H. J. Clin. Psychiatry (2001) [Pubmed]
  26. Panic: course, complications and treatment of panic disorder. Pollack, M.H., Marzol, P.C. J. Psychopharmacol. (Oxford) (2000) [Pubmed]
  27. Sertraline treatment of panic disorder: response in patients at risk for poor outcome. Pollack, M.H., Rapaport, M.H., Clary, C.M., Mardekian, J., Wolkow, R. J. Clin. Psychiatry (2000) [Pubmed]
  28. Social anxiety disorder: designing a pharmacologic treatment strategy. Pollack, M.H. J. Clin. Psychiatry (1999) [Pubmed]
  29. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Pollack, M.H., Otto, M.W., Worthington, J.J., Manfro, G.G., Wolkow, R. Arch. Gen. Psychiatry (1998) [Pubmed]
 
WikiGenes - Universities